Plexus Corp. (NASDAQ:PLXS) Receives $107.75 Average PT from Analysts

Shares of Plexus Corp. (NASDAQ:PLXSGet Free Report) have been assigned a consensus rating of “Moderate Buy” from the four ratings firms that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $107.75.

A number of analysts have recently issued reports on the stock. Stifel Nicolaus raised their target price on shares of Plexus from $90.00 to $95.00 and gave the stock a “hold” rating in a research note on Friday, April 26th. TheStreet lowered shares of Plexus from a “b” rating to a “c+” rating in a research report on Tuesday, February 13th. Finally, Needham & Company LLC raised their price target on shares of Plexus from $107.00 to $114.00 and gave the stock a “buy” rating in a research report on Friday, April 26th.

Check Out Our Latest Stock Analysis on Plexus

Plexus Stock Performance

Shares of PLXS opened at $111.42 on Tuesday. Plexus has a 12 month low of $86.41 and a 12 month high of $114.19. The firm has a fifty day simple moving average of $99.38 and a 200 day simple moving average of $100.13. The stock has a market capitalization of $3.05 billion, a price-to-earnings ratio of 30.78 and a beta of 1.00. The company has a current ratio of 1.51, a quick ratio of 0.64 and a debt-to-equity ratio of 0.15.

Plexus (NASDAQ:PLXSGet Free Report) last announced its quarterly earnings results on Wednesday, April 24th. The technology company reported $0.94 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.07. The firm had revenue of $966.90 million during the quarter, compared to analysts’ expectations of $950.75 million. Plexus had a net margin of 2.54% and a return on equity of 10.77%. The company’s revenue for the quarter was down 9.7% compared to the same quarter last year. During the same quarter last year, the company posted $1.45 earnings per share. Research analysts forecast that Plexus will post 3.81 EPS for the current fiscal year.

Insider Buying and Selling at Plexus

In other Plexus news, CFO Patrick John Jermain sold 4,999 shares of the firm’s stock in a transaction dated Monday, May 20th. The shares were sold at an average price of $110.00, for a total value of $549,890.00. Following the transaction, the chief financial officer now directly owns 34,183 shares of the company’s stock, valued at approximately $3,760,130. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other Plexus news, CFO Patrick John Jermain sold 4,999 shares of the firm’s stock in a transaction dated Monday, May 20th. The shares were sold at an average price of $110.00, for a total value of $549,890.00. Following the transaction, the chief financial officer now directly owns 34,183 shares of the company’s stock, valued at approximately $3,760,130. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Todd P. Kelsey sold 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 29th. The shares were sold at an average price of $94.00, for a total transaction of $188,000.00. Following the completion of the sale, the chief executive officer now owns 121,310 shares in the company, valued at $11,403,140. The disclosure for this sale can be found here. Insiders have sold a total of 36,230 shares of company stock valued at $3,760,719 in the last ninety days. 2.39% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Plexus

A number of hedge funds have recently made changes to their positions in the stock. Parallel Advisors LLC lifted its position in shares of Plexus by 72.3% in the 4th quarter. Parallel Advisors LLC now owns 348 shares of the technology company’s stock worth $38,000 after purchasing an additional 146 shares during the period. Congress Asset Management Co. MA increased its stake in shares of Plexus by 1.1% in the 1st quarter. Congress Asset Management Co. MA now owns 16,273 shares of the technology company’s stock valued at $1,543,000 after acquiring an additional 184 shares in the last quarter. CANADA LIFE ASSURANCE Co increased its stake in shares of Plexus by 0.9% in the 1st quarter. CANADA LIFE ASSURANCE Co now owns 23,461 shares of the technology company’s stock valued at $2,219,000 after acquiring an additional 209 shares in the last quarter. Moran Wealth Management LLC increased its stake in shares of Plexus by 0.5% in the 4th quarter. Moran Wealth Management LLC now owns 48,809 shares of the technology company’s stock valued at $5,278,000 after acquiring an additional 230 shares in the last quarter. Finally, Inspire Investing LLC increased its stake in shares of Plexus by 6.7% in the 1st quarter. Inspire Investing LLC now owns 3,803 shares of the technology company’s stock valued at $361,000 after acquiring an additional 238 shares in the last quarter. 94.45% of the stock is currently owned by institutional investors and hedge funds.

About Plexus

(Get Free Report

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Featured Articles

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.